首页 | 本学科首页   官方微博 | 高级检索  
检索        

速避凝治疗慢性肺心病的临床观察
引用本文:段节,吴尚洁.速避凝治疗慢性肺心病的临床观察[J].湖南医科大学学报,1998,23(5):470-472.
作者姓名:段节  吴尚洁
摘    要:为探讨皮下注射速避凝对慢性肺心病急性期的疗效,于治疗前后同步检测20例患者的纤维蛋白降解产物(FDP,D-二聚体)抗凝血酶原Ⅲ(AT-Ⅲ),动脉血氧分压(PaO2)及动脉血二氧化碳分压,结果示:治疗组FDP和D-二聚体治疗后较治疗前显著降低(P〈0.01),AT-Ⅲ则显著升高(P〈0.01),血气参数显著改善(P〈0.01);对照组(未用速避凝)治疗前后的各项检测指标差异均无显著性(P〉0.05)

关 键 词:慢性  肺心病  速避凝  药物疗法

Chronic pulmonary heart diseases treated by fraxiparin]
S Duan,S Wu,P Chen.Chronic pulmonary heart diseases treated by fraxiparin][J].Bulletin of Hunan Medical University,1998,23(5):470-472.
Authors:S Duan  S Wu  P Chen
Institution:Department of Internal Medicine, Second Affiliated Hospital, Hunan Medical University, Changsha.
Abstract:OBJECTIVE: The effects of fraxiparine with hypodermic on the treatment of patients with chronic pulmonary heart diseases(CPHD) at acute phase were studied. METHODS: Twenty patients were hypodermically injected with 0.4 ml fraxiparine per day for 7 days as a course. Fibrin fibrinogen degradation products (FDP and D-dimer), antithrombin III (AT-III), PaO2 and PaCO2 were detected before and after the treatment. RESULTS: In the therapy group, FDP and D-dimer decreased after the treatment, AT-III increased. All indexes didn't alter in the control group. CONCLUSION: Fraxiparine is effective on patients with CPHD at acute phase.
Keywords:
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号